Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 11642505 was granted and assigned to Hisamitsu Pharmaceutical on May, 2023 by the United States Patent and Trademark Office. | 11642505 | May 9, 2023 | |||||||
Patent 11400053 was granted and assigned to Hisamitsu Pharmaceutical on August, 2022 by the United States Patent and Trademark Office. | 11400053 | August 2, 2022 | |||||||
Patent 11033458 was granted and assigned to Hisamitsu Pharmaceutical on June, 2021 by the United States Patent and Trademark Office. | 11033458 | June 15, 2021 | |||||||
Patent 10940121 was granted and assigned to Hisamitsu Pharmaceutical on March, 2021 by the United States Patent and Trademark Office. | 10940121 | March 9, 2021 | |||||||
11464956 | October 11, 2022 | ||||||||
Patent 11364207 was granted and assigned to Hisamitsu Pharmaceutical on June, 2022 by the United States Patent and Trademark Office. | 11364207 | June 21, 2022 | |||||||
Patent 11020356 was granted and assigned to Hisamitsu Pharmaceutical on June, 2021 by the United States Patent and Trademark Office. | 11020356 | June 1, 2021 | |||||||
Patent D926031 was granted and assigned to Hisamitsu Pharmaceutical on July, 2021 by the United States Patent and Trademark Office. | D926031 | July 27, 2021 | |||||||
Patent 11607394 was granted and assigned to Hisamitsu Pharmaceutical on March, 2023 by the United States Patent and Trademark Office. | 11607394 | March 21, 2023 | |||||||
Patent 11033511 was granted and assigned to Hisamitsu Pharmaceutical on June, 2021 by the United States Patent and Trademark Office. | 11033511 | June 15, 2021 | |||||||
Patent 10888532 was granted and assigned to Hisamitsu Pharmaceutical on January, 2021 by the United States Patent and Trademark Office. | 10888532 | January 12, 2021 | |||||||
Patent D985232 was granted and assigned to Hisamitsu Pharmaceutical on May, 2023 by the United States Patent and Trademark Office. | D985232 | May 9, 2023 | |||||||
Patent 11219601 was granted and assigned to Hisamitsu Pharmaceutical on January, 2022 by the United States Patent and Trademark Office. | 11219601 | January 11, 2022 | |||||||
Patent 10898448 was granted and assigned to Hisamitsu Pharmaceutical on January, 2021 by the United States Patent and Trademark Office. | 10898448 | January 26, 2021 | |||||||
Patent 11246830 was granted and assigned to Hisamitsu Pharmaceutical on February, 2022 by the United States Patent and Trademark Office. | 11246830 | February 15, 2022 | |||||||
Patent 9918945 was granted and assigned to Hisamitsu Pharmaceutical on March, 2018 by the United States Patent and Trademark Office. | 9918945 | March 20, 2018 | |||||||
10828480 | November 10, 2020 | ||||||||
Patent 10987502 was granted and assigned to Hisamitsu Pharmaceutical on April, 2021 by the United States Patent and Trademark Office. | 10987502 | April 27, 2021 | |||||||
Patent 11202764 was granted and assigned to Hisamitsu Pharmaceutical on December, 2021 by the United States Patent and Trademark Office. | 11202764 | December 21, 2021 | |||||||
Patent 10869998 was granted and assigned to Hisamitsu Pharmaceutical on December, 2020 by the United States Patent and Trademark Office. | 10869998 | December 22, 2020 | |||||||
Patent 11007358 was granted and assigned to Hisamitsu Pharmaceutical on May, 2021 by the United States Patent and Trademark Office. | 11007358 | May 18, 2021 | |||||||
Patent D510702 was granted and assigned to Hisamitsu Pharmaceutical on October, 2005 by the United States Patent and Trademark Office. | D510702 | October 18, 2005 | |||||||
Patent 6924410 was granted and assigned to Hisamitsu Pharmaceutical on August, 2005 by the United States Patent and Trademark Office. | 6924410 | August 2, 2005 | |||||||
Patent 6936268 was granted and assigned to Hisamitsu Pharmaceutical on August, 2005 by the United States Patent and Trademark Office. | 6936268 | August 30, 2005 | |||||||
11660268 | May 30, 2023 |